Welt is a common skin condition that affects skin from both the forehead and nose.
It can also cause blisters and breakouts.
The condition can be treated with creams, lotions and sprays.
However, there are no drugs or surgery to treat it.
Instead, it is common to see people who have this condition come in with a nagging itch that has become infected with a new virus, called a viral graze, and have to get a second round of antibiotics.
In the last few years, researchers have been investigating a new treatment, the treatment of the nudge, or the use of a nudge in a way that is less invasive than the antibiotics used for other types of skin infections.
Nudge Therapy is a term that means treating the infection in a non-invasive way with a medication.
It works by using a gentle pressure or pressure that is applied on a person’s skin to help it shed infected cells.
It is the first treatment that has been proven to be effective in the treatment and prevention of skin infection.
Dr Helen Brown, an expert in infectious disease, said nudge therapy could be the new standard in the field.
Dr Brown said there were a number of new therapies, including a nasal spray that works by removing bacteria from the nasal passages.
Dr Martin Todt, the director of research and innovation at the Australian Institute of Health and Welfare (AIHW), said the nudges could also be used to treat other conditions.
Nudges may not have a clear benefit on the condition but they may be a useful alternative to other treatments because they are very effective at treating infections in patients with multiple conditions.
He said it was also worth considering the possibility that these treatments could be effective at preventing future infections and outbreaks.
Dr Todd said while nudge therapies had not been tested in humans, they had demonstrated efficacy in preventing skin infections and that the new treatment could be considered an effective alternative to existing treatments.
The ABC spoke to one of the researchers who has been studying the treatment.
Dr Susan Fagan said that there had been a lot of excitement about the potential of this treatment.
She said the initial results from the trials were encouraging and the research was ongoing.
Dr Fagan also said that this treatment would be available soon to patients with other skin conditions.
She was optimistic that it would be a safe and effective treatment and said that the next phase of testing was to determine if it was safe for people with skin conditions like psoriasis, eczema and psorosis.
She did say that the researchers were now looking into how to improve the effectiveness of the treatment over time.